Spotlight
About
News
CME/CE
Subscribe
Partnerships
Timing of hormone therapy and Alzheimer's disease
Women who begin hormone therapy (HT) within 5 years of menopause have a lower risk of Alzheimer's disease (AD) than those who do not use HT, so say the findings of a population-based study.
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Recent Videos
Related Content
